(Q42953220)

11 November 2017

title

Targeted therapies: Biomarkers in NSCLC for selecting cetuximab therapy (English)

1 reference

non-small-cell lung carcinoma

11 November 2017

0 references

1 reference

1 reference

Thomas E Stinchcombe

1

1 reference

11 November 2017

Mark A Socinski

series ordinal

2

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

Nature Reviews Clinical Oncology

11 November 2017

published in

1 reference

11 November 2017

volume

7

1 reference

11 November 2017

issue

8

1 reference

11 November 2017

page(s)

426-428

1 reference

Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.99

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.99

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.99

Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.99

Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.99

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.99

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.99

10.1038/NRCLINONC.2010.99

31 March 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

11 November 2017

1035481398

0 references

1 reference